1487 results about "Patient compliance" patented technology

The invention relates to a multiparticulate modified release composition that in operation delivers an active ingredient in a pulsed or bimodal manner. The multiparticulate modified release composition comprises an immediate release component and a modified release component; the immediate release component comprising a first population of active ingredient containing particles and the modified release component compnsimg a second population of active ingredient containing particles coated with a controlled release coating; wherein the combination of the immediate release and modified release components in operation deliver the active ingredient in a pulsed or a bimodal manner. The invention also relates to a solid oral dosage form containing such a multiparticulate modified release composition. The plasma profile achieved by the multiparticulate modified release composition is advantageous in reducing patient tolerance to the active ingredient and in increasing patient compliance by reducing dosage frequency.

A system and methods is provided for facilitating, monitoring and recording caregiver and patient compliance with established hospital hand hygiene protocols. The system comprises a 3-D imaging and monitoring assembly and an optional intelligent programmable monitor/sanitizer. Three dimensional imagery tracks a caregiver's movements and location while generating a representative image value. Information acquired by the imaging system determines the proximity of a caregiver to the patient and/or contamination source and determines if the sanitizers provided have been utilized and if so, at an appropriate time and distance from the patient per hospital protocol. While being monitored, a representative Avatar based on physical characteristics derived from three dimensional images of the caregiver and patient may be generated so as to maintain anonymity of both unless a violation of institutional protocol occurs which may be forensically recorded in real-time for analysis.

A treatment Device is provided which enables a Doctor/Pharmacist to provide patient specific instructions in a textual format to a patient. The instructions are converted by a speech synthesizer provided in the Device into an audibly perceptible format. When configured as a hand-held unit, the Device may store a plurality of medications. Upon activation or automatically, instructions saved in the device are communicated to a patient/user via various audible, visual and/or tactile indicators. The instructions are provided to the device via a Platform which enables Doctors and Pharmacists input instructions into the Platform, which, via a Platform interface, are saved into a storage device provided in the Device. In an additional embodiment, a removable medication dispensing cartridge is provided which facilitates the controlled and automatic dispensing of a medication to a patient based upon a treatment schedule. Patient compliance information with a treatment schedule may be provided by the Device.

The Electronic Compliance Promoter is a computer system for increasing a patient's compliance with medical post-care treatment instructions. The system permits the patient to review the treatment instructions that have been entered into a treatment instructions database by medical personnel at the time of the examination. The system includes a patient-client computer interface, a medical person-client interface, a treatment instructions database, and a compliance-server program. The database contains the post-visit care instructions and other types of information that the patient should have to understand and follow those instructions. The database also has treatment guideline information to assist the doctor in formulating the post-care treatment instructions. The patients client-computer interface provides a knowledge-based means for the patient to review interactively the Doctor's after care instructions, and measures compliance by tracking a patients' use of the specific designated diagnosis related resources. The medical personnel client-computer interface provides a knowledge-based means to designate the post-care medical visit instructions the patient is to follow. The compliance-server program tracks patients compliance and can send messages to patients reminding them to review the post-care treatment instructions. The Electronic Compliance Promoter system provides a means to significantly increase a patient's compliance with medical care instructions.

This invention describes the use of pharmaceutical compositions, which comprise three components of which at least one is a slow release therapeutic agent. Such useful compositions are applicable for the treatment of humans suffering from diabetic, hypertensive, cardiovascular, hyperlipidemic conditions and their associated disorders thereof. Combination therapy has the advantages of better patient compliance; better therapeutic efficacy coupled with a reduction in the dose for some of the individual therapeutic agent(s) in the combination.

Oral dosage forms of a bisphosphonate comprised of a safe and effective amount of a pharmaceutical composition comprising a bisphosphonate, a chelating agent, and, means for effecting delayed release of the bisphosphonate and the chelating agent in the lower gastrointestinal tract provide delivery of the pharmaceutical composition to the lower gastrointestinal tract of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between bisphosphonates and food or beverages, which interaction results in the bisphosphonate active ingredient not being available for absorption. The resulting oral dosage form may thus be taken with or without food. Further, the present invention effects delivery of the bisphosphonate and the chelating agent to the lower GI tract, substantially alleviating the upper GI irritation associated with bisphosphonate therapies. These benefits simplify previously complex treatment regimens and can lead to increased patient compliance with bisphosphonate therapies.

An individualized system and method of mass diagnosis and treatment of obesity that is optionally configurable for a plurality of patients and health providers. Computer and relational data storage systems are used for operating a computer program and a secure web site on an internet. User profiles are assigned for accessing the secure web site using a plurality of computer terminals. Patient data and information are gathered for use in a health risk analysis to determine values for variables in a caloric energy equation. An individualized health provider web page is used to administer a meal plan, an exercise plan and an education plan to influence variables in the caloric energy equation to derive an individualized caloric energy deficit and a starvation response threshold in the patient. Patient compliance information is gathered for use in the health risk analysis and for correlation with the stored data to re-derive the variables.

Methods and systems for enabling and supporting patient compliance with a health treatment program or with health-related instructions from a caregiver are described. An interactive feedback loop is implemented that enhances and improves on present methods of monitoring and supporting patient compliance with treatment programs, particularly for patients with chronic conditions. A patient enters various types of data (e.g., biometric readings, diary entries, responses to surveys and health assessments, etc.) to a health data management system that includes a patient compliance monitoring system. The patient is encouraged to enter as much data as is practical and as frequently as possible. The feedback loop of the present invention provides compliance messages to the patient in a timely manner that are responsive to the data entered by the patient. The messages are customized, supportive, and timely. The system can also implement a reward scheme in which patients who go beyond their prescribed treatment program or consistently stay within a compliance range obtain direct financial benefits or rewards. The system also allows patients to sends feedback on the messages he or she receives from the system. This feedback can be used to measure the effectiveness of a treatment program or of the monitoring system itself. Healthcare professionals play an active role in tailoring and “signing off” the compliance-related messages that the patient receives.

The present invention is directed to a combination treatment of an opioid antagonist e.g., naltrexone and a second compound selected from the group consisting of a GABA B agonist, an NMDA antagonist, a serotonin antagonist, and a cannabinoid antagonist is the key to the successful treatment of a brain reward system disorder. A brain reward system, include but are not limited, to pathological gambling, compulsive alcohol consumption, compulsive over-eating and obesity, compulsive smoking, and drug addiction. The compounds and methods of the present invention effectively reduce the cravings, withdrawal symptoms and negative drug side effects associated with a monotherapy. As such, patient compliance is greatly increased, thereby decreasing relapse of a brain reward system disorder.

The subject invention provides systems and methods for monitoring prescription medications. In particular, systems and methods are provided for monitoring patient compliance with a given prescribed regimen as well as monitoring the origins of a prescription drug. The subject invention provides a central computer and a portable device, wherein the portable device includes at least one sensor for detecting a target marker. The target marker of the invention represents either the presence of a specific prescribed medication or identify the proper origins of a medication.

Apparatus for delivery of humidified gases therapy includes a humidifier. A recorder records. An output interface allows for outputting of the recorded data. The recorder may also record data indicative of patient compliance with the humidified gases therapy. The apparatus may determine patient compliance from sensed delivered flow.

Recorded humidity and compliance data retrieved from the apparatus are useful in methods for improving the efficacy of humidified gases therapy or diagnosing problems with the efficacy of humidified gases therapy.

Systems, apparatuses, and methods for tracking the status and use of packaged goods are provided. The systems of the invention coordinate various stakeholders, hardware devices, computer software systems, standards, methods, procedures, practices and their interconnection in ways that lead to greater efficiency, safety, and efficacy, along with potentially lower cost, and less waste in the delivery of packaged goods and their use. In one aspect a Medication Management System (“MMS”) that tracks the status of packaged medications and patient compliance is also provided.

A method of operating a device for treating sleep disordered breathing (SDB), wherein the device provides continuous positive airway pressure during sleep, includes applying a treatment pressure to a patient, monitoring the patient for speech output, generating a signal in response to detected speech of the patient, and, in response to the signal, reducing the treatment pressure applied to the patient.

An alternate drug delivery system for dissolution of pharmaceuticals in the mouth wherein a therapeutically effective amount of a drug is encapsulated using an encapsulation method. Encapsulation reduces the perceived off flavors of drugs, allowing the active components to dissolve pleasantly in the mouth. This allows more rapid absorption of the active compounds through the oral cavity compared to traditional tablets, which require breakdown and absorption in the gastrointestinal tract. The delivery system can be incorporated into a variety of applications, such as breath mint tablets or chewing gum. Benefits of this invention include portability and the ability to take pharmaceuticals without water and without the off taste of chewable tablets, thereby leading to increased patient compliance.

The present invention is directed to pharmaceutical compositions that allow for once-daily or alternate day dosage forms of topiramate. The proposed delayed/extended release single dosage form is equivalent to the immediate-release multiple dose daily regimen, and upon administration, provides steady state blood levels of topiramate. Formulations with increased bioavailability and improved pharmacokinetics are disclosed. A once-a-day administration of topiramate is advantageous over the multiple dose regimen both in terms of patient compliance and reduced adverse events, thus providing better treatment of the conditions for which the topiramate is indicated.